Delivery Order SPE2DB22D2206-SPE2DB24FEW05
Award Date
12/28/23
Potential Completion Date
12/29/23
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $34,823.14 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of the pharmaceutical product ONTRUZANT 420 MG VIALS, with a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $62,776.72 contract is for the delivery of 4,565,631,436 vials of the pharmaceutical product ONTRUZANT 420 MG. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, was awarded this delivery order through the company's Indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $32,720.00 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the supply of ONTRUZANT 420 MG VIALS. This award is part of a larger indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ONTRUZANT 420 MG VIALS. The contract has a firm fixed price of $53,643.41 and a completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ONTRUZANT 150 MG vials, with a completion date of March 6, 2024 and a potential value of $1,436.46. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and has...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,422.97 firm fixed price contract is for the delivery of ONTRUZANT 150 MG VIALS. This order does not have a set-aside designation and is scheduled for completion by January 4, 2024. Amerisourcebergen Drug Corp has...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide ONTRUZANT 150 MG VIALS. The $11,918.06 award has a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4563472549 units of ONTRUZANT 420 MG VIALS. The contract has a potential value of $29,220.76 and a completion date of January 30, 2024. This award is part of Amerisourcebergen Drug Corp's broader portfolio of federal contracts with DLA and the Department of Justice Federal Bureau of Investigation,...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $10,534.04 and has an ultimate completion date of April 12, 2024. It is for the provision of the pharmaceutical drug ONTRUZANT 150 MG VIALS. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug...
This is a $9,576.40 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...